Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
about
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.A Review of Antiviral Use for the Treatment of Chronic Hepatitis B Virus Infection in Pregnant Women.Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.Chronic hepatitis B infection in pregnancyAntiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis.Comprehensive review of telbivudine in pregnant women with chronic hepatitis B.Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus.Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis.Hepatitis B virus infection in children.Telbivudine therapy for chronic hepatitis B: A journey to identify super-responders and to optimize treatment using the roadmap model.The epidemiology of hepatitis B virus infection in women of reproductive age in highly endemic areas in China.Pharmacotherapeutic options for hepatitis B.A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection.DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.Congenital and perinatally-acquired infections in resource-constrained settings.Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B.Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus.Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection.Viral hepatitis and liver cancer.Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.Third-trimester tenofovir to prevent mother-to-child hepatitis B virus transmission.Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: a multicenter prospective cohort study.Prospective cohort study on the efficacy and safety of telbivudine used throughout pregnancy in blocking mother-to-child transmission of hepatitis B virus.Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).Management of Pregnant Women and Children: Focusing on Preventing Mother-to-Infant Transmission.Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment.Bringing to an end mother-to-child transmission of hepatitis B: A role for quantitative hepatitis B surface antigen?Hepatitis B Virus Infection in Tanzania: Current Status and Challenges.Perinatal management of hepatitis B virus: Clinical implementation of updated Australasian management guidelines.A Public Health Analysis on Gaps in Disease Monitoring and Opportunities for Improved Care for the Management of Hepatitis B and C.An expert consensus for the management of chronic hepatitis B in Asian Americans.Ending vertical transmission of hepatitis B: the third trimester intervention.Liver Disease During Pregnancy: A Challenging Clinical Issue.Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities
P2860
Q30391932-819EA353-8A19-4771-8CFA-43E19BA8606DQ33711399-C0559CE5-845A-4AF9-8CB5-EC0141283ADEQ33829957-13BC4407-A3C5-4C3D-85B3-AFD7F9092793Q35626775-56FFB337-39A4-4699-8CC2-685002F285A6Q35840548-400CD9C0-54DB-4628-8C64-E09ED7FAAC80Q36727510-054F838D-ECCC-4F78-AA73-C2BAF3C59FA3Q36738003-C8E40360-B78C-4E81-A5E3-E32CE54C76A1Q36777589-8DA476D3-608D-4208-BA62-A4B956A8B67CQ38365905-941B51B5-D9EB-4D0A-B05A-E1BB711838FEQ38559455-429DD1B6-27FC-4BB9-B243-BE76517C6D7CQ38611779-0B2B8C2A-6CF2-4BF1-A162-3AA449917633Q38631076-947CF0C1-D92F-4D45-B6C3-373A47412A28Q38632945-E956F348-E224-45BF-9A43-7E747CA54583Q38692333-D2A3FA3F-669E-42DC-AA58-59F9716428A8Q38904188-7FE44D1E-7C05-4F6C-B09E-5F8B861881DAQ39062913-1368AF69-1337-47BB-AE45-0A4A963F1B84Q39256818-62B9074D-02D7-4B83-8062-BAF6C0AA01FDQ39781470-0AF35390-E9FB-4107-A5D0-C69778BF3FC8Q39864436-6E18FC9E-4C95-48EF-A236-A63F4CE7D634Q40046596-950902EB-B7A2-4C72-B377-2BC10C84B5E0Q40046821-3733C6F9-A8EA-4F46-BBE4-3284C5775591Q40389666-48289095-143D-403C-93D8-0042A4B5FD25Q40600289-6FF249E7-4D37-4531-8B72-C260614F5E46Q41349327-8AC05784-9EBC-4B09-BA94-A4F1F11A824EQ41918890-48F52C2F-9B02-4EF3-93F0-966230DDC2E6Q45073764-8A5DD575-6974-47D4-B484-BEA452F69161Q45323953-4C3D5704-D8B7-403D-8129-FC5D491D094FQ45325519-5499860A-58D4-4D35-80B5-201EAD59A1AFQ47142488-68C1FA8D-AC99-4031-9580-42D7F9B08597Q47575321-6CA6B4CB-D169-4E6E-8E94-FEC58F873617Q47596434-7B4B4BFD-A5F9-42D1-BC63-5827E3A5A6DAQ48022236-D638AA27-7CF3-4BFF-B63D-3D08B78E71F0Q52318586-D4F9E880-CA02-488A-9C18-E02E2F3FA55DQ52595153-0F915E17-0F30-45EC-A762-166BFA105015Q52645814-A95053A1-88CA-47F9-8627-E7AE9724B04CQ52685884-6A63E5A1-3026-40A6-8E17-F8D64DAE31F5Q55042729-8EDBCBC5-C38C-431C-8AF0-D54D4B91F54BQ55508399-1283C534-F852-4E7B-A718-A0EC77C7A81BQ55711692-BED1498A-2A73-4BF4-94C0-353BA2898CCCQ57171795-8A7E01F4-310A-401E-B617-44B4428CA023
P2860
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Telbivudine or lamivudine use ...... B virus in real-life practice.
@ast
Telbivudine or lamivudine use ...... B virus in real-life practice.
@en
Telbivudine or lamivudine use ...... B virus in real-life practice.
@nl
type
label
Telbivudine or lamivudine use ...... B virus in real-life practice.
@ast
Telbivudine or lamivudine use ...... B virus in real-life practice.
@en
Telbivudine or lamivudine use ...... B virus in real-life practice.
@nl
prefLabel
Telbivudine or lamivudine use ...... B virus in real-life practice.
@ast
Telbivudine or lamivudine use ...... B virus in real-life practice.
@en
Telbivudine or lamivudine use ...... B virus in real-life practice.
@nl
P2093
P2860
P356
P1433
P1476
Telbivudine or lamivudine use ...... B virus in real-life practice.
@en
P2093
Calvin Q Pan
Qiumei Pang
Ruihua Tian
P2860
P304
P356
10.1002/HEP.27034
P407
P577
2014-08-01T00:00:00Z